Details of Drug

Drug General Information (ID: D0720)
Drug Name	Gilteritinib
Drug Type	Small molecule
Drug Synonymous	UNII-66D92MGC8M; 66D92MGC8M; Gilteritinib [USAN:INN]; Gilteritinib(ASP2215); Gilteritinib (USAN/INN); Gilteritinib (ASP2215); Gilteritinib (ASP-2215); SCHEMBL282229; GTPL8708; MolPort-038-934-933; BDBM144315; C29H44N8O3; 3694AH; s7754; AKOS030234455; ZINC113476229; DB12141; CS-3885; KS-0000064E; AS-35199 Click to Show/Hide
Disease Class	2A60: Acute myeloid leukaemia
Therapeutic Class	Multikinase Inhibitors
Structure
Structure	3D Structure		2D Structure
Formula	C29H44N8O3
InChI	1S/C29H44N8O3/c1-4-23-28(31-20-9-17-40-18-10-20)34-29(26(33-23)27(30)38)32-21-5-6-24(25(19-21)39-3)37-11-7-22(8-12-37)36-15-13-35(2)14-16-36/h5-6,19-20,22H,4,7-18H2,1-3H3,(H2,30,38)(H2,31,32,34)
InChIKey	GYQYAJJFPNQOOW-UHFFFAOYSA-N
Canonical SMILES	CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5
External Link
	Pubchem ID	49803313
	CAS Number	1254053-43-4
	CHEBI ID	145372
	TTD ID	D04KZY
	INTEDE ID	DR0772
	VARIDT ID	DR00358

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM002 Affected cellular transport AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM010 Transporter inhibition BM011 Transporter induction BM017 CYP450 enzyme inhibition BM022 CYP450 enzyme induction BM038 Additive CNS depression effects BM044 Additive myelosuppressive effects BM055 Increased risk of hepatotoxicity BM076 Increased risk of prolong QT interval BM081 Increased risk of ventricular arrhythmias BM098 Antagonize the effect of serotonergic agents BM109 Increased risk of other adverse reactions (Unspecific)
Relation Graph

Full list of drugs interacting with Gilteritinib
Affected cellular transport
	Transporter inhibition					Drug Num: 71
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0380		Colchicine	C22H25NO6	6167	Major		Inter Info	[48], [49], [50]
D0551		Edoxaban	C24H30ClN7O4S	10280735	Major		Inter Info	[3], [57], [58], [59]
D0038		Aliskiren	C30H53N3O6	5493444	Moderate		Inter Info	[1], [3], [162], [163]
D0096		Apixaban	C25H25N5O4	10182969	Moderate		Inter Info	[3], [164], [165]
D0099		Apremilast	C22H24N2O7S	11561674	Moderate		Inter Info	[2], [3], [15]
D0120		Atorvastatin	C33H35FN2O5	60823	Moderate		Inter Info	[2], [3], [15]
D0130		Avatrombopag	C29H34Cl2N6O3S2	9852519	Moderate		Inter Info	[2], [3], [15]
D0153		Belinostat	C15H14N2O4S	6918638	Moderate		Inter Info	[2], [3], [15]
D0227		Cabazitaxel	C45H57NO14	9854073	Moderate		Inter Info	[2], [3], [15]
D0251		Capmatinib	C23H17FN6O	25145656	Moderate		Inter Info	[208]
D0254		Captopril	C9H15NO3S	44093	Moderate		Inter Info	[3], [15]
D0267		Carvedilol	C24H26N2O4	2585	Moderate		Inter Info	[3], [15]
D0313		Chloramphenicol	C11H12Cl2N2O5	5959	Moderate		Inter Info	[3], [15]
D0348		Cladribine	C10H12ClN5O3	20279	Moderate		Inter Info	[2], [3], [15]
D0376		Cobimetinib	C21H21F3IN3O2	16222096	Moderate		Inter Info	[210]
D0408		Daclatasvir	C40H50N8O6	25154714	Moderate		Inter Info	[3], [15]
D0438		Delafloxacin	C18H12ClF3N4O4	487101	Moderate		Inter Info	[2], [3], [15]
D0491		Digoxin	C41H64O14	2724385	Moderate		Inter Info	[2], [3], [15]
D0511		Docetaxel	C43H53NO14	148124	Moderate		Inter Info	[2], [3], [15]
D0555		Elagolix	C32H30F5N3O5	11250647	Moderate		Inter Info	[3], [15]
D0559		Eliglustat	C23H36N2O4	23652731	Moderate		Inter Info	[3], [15]
D0561		Eltrombopag	C25H22N4O4	135449332	Moderate		Inter Info	[2], [3], [15]
D0565		Empagliflozin	C23H27ClO7	11949646	Moderate		Inter Info	[2], [3], [15]
D0627		Etoposide	C29H32O13	36462	Moderate		Inter Info	[2], [3], [15]
D0629		Everolimus	C53H83NO14	6442177	Moderate		Inter Info	[216], [165]
D0656		Fexofenadine	C32H39NO4	3348	Moderate		Inter Info	[2], [3], [15]
D0176		Betrixaban	C23H22ClN5O3	10275777	Moderate		Inter Info	[220]
D0726		Glecaprevir	C38H46F4N6O9S	66828839	Moderate		Inter Info	[3], [15]
D0963		Lusutrombopag	C29H32Cl2N2O5S	49843517	Moderate		Inter Info	[13]
D1324		Pralsetinib	C27H32FN9O2	129073603	Moderate		Inter Info	[2], [3], [15]
D1407		Rimegepant	C28H28F2N6O3	51049968	Moderate		Inter Info	[225]
D1663		Ubrogepant	C29H26F3N5O3	68748835	Moderate		Inter Info	[226]
D0745		Guanfacine	C9H9Cl2N3O	3519	Moderate		Inter Info	[2], [3], [15]
D0785		Ibrutinib	C25H24N6O2	24821094	Moderate		Inter Info	[3], [15]
D0845		Irinotecan	C33H38N4O6	60838	Moderate		Inter Info	[2], [3], [15]
D0846		Irinotecan (liposomal)	C33H38N4O6	60838	Moderate		Inter Info	[2], [3], [15]
D0898		Ledipasvir	C49H54F2N8O6	67505836	Moderate		Inter Info	[3], [15]
D0930		Linagliptin	C25H28N8O2	10096344	Moderate		Inter Info	[2], [3], [15]
D0961		Lurasidone	C28H36N4O2S	213046	Moderate		Inter Info	[2], [3], [15]
D0980		Maraviroc	C29H41F2N5O	3002977	Moderate		Inter Info	[235]
D1015		Metformin	C4H11N5	4091	Moderate		Inter Info	[2], [3], [15]
D1089		Morphine	C17H19NO3	5288826	Moderate		Inter Info	[2], [3], [15]
D1101		Naldemedine	C32H34N4O6	54732242	Moderate		Inter Info	[2], [3], [15]
D1124		Neratinib	C30H29ClN6O3	9915743	Moderate		Inter Info	[3], [15]
D1134		Nifedipine	C17H18N2O6	4485	Moderate		Inter Info	[3], [15]
D1139		Nintedanib	C31H33N5O4	135423438	Moderate		Inter Info	[2], [3], [15]
D1140		Niraparib	C19H20N4O	24958200	Moderate		Inter Info	[2], [3], [15]
D1212		Paclitaxel	C47H51NO14	36314	Moderate		Inter Info	[2], [3], [15]
D1213		Paclitaxel (protein-bound)	C47H51NO14	36314	Moderate		Inter Info	[2], [3], [15]
D1362		Prucalopride	C18H26ClN3O3	3052762	Moderate		Inter Info	[2], [3], [15]
D1402		Rifaximin	C43H51N3O11	6436173	Moderate		Inter Info	[2], [3], [15]
D1408		Riociguat	C20H19FN8O2	11304743	Moderate		Inter Info	[2], [3], [15]
D1417		Rivaroxaban	C19H18ClN3O5S	9875401	Moderate		Inter Info	[2], [3], [15]
D1423		Rolapitant	C25H26F6N2O2	10311306	Moderate		Inter Info	[255]
D1445		Sarecycline	C24H29N3O8	54681908	Moderate		Inter Info	[3], [15]
D1449		Saxagliptin	C18H25N3O2	11243969	Moderate		Inter Info	[2], [3], [15]
D1457		Selexipag	C26H32N4O4S	9913767	Moderate		Inter Info	[2], [3], [15]
D1466		Silodosin	C25H32F3N3O4	5312125	Moderate		Inter Info	[2], [3], [15]
D1476		Sirolimus	C51H79NO13	5284616	Moderate		Inter Info	[2], [3], [15]
D1517		Sulfasalazine	C18H14N4O5S	5339	Moderate		Inter Info	[2], [3], [15]
D1524		Suvorexant	C23H23ClN6O2	24965990	Moderate		Inter Info	[3], [15]
D1532		Talazoparib	C19H14F2N6O	135565082	Moderate		Inter Info	[256]
D1610		Topotecan	C23H23N3O5	60700	Moderate		Inter Info	[2], [3], [15]
D1617		Trametinib	C26H23FIN5O4	11707110	Moderate		Inter Info	[2], [3], [15]
D1664		Ulipristal	C28H35NO3	13559281	Moderate		Inter Info	[3], [15]
D1686		Velpatasvir	C49H54N8O8	67683363	Moderate		Inter Info	[3], [15]
D1697		Vinblastine	C46H58N4O9	13342	Moderate		Inter Info	[2], [3], [15]
D1699		Vincristine (liposome)	C46H56N4O10	5978	Moderate		Inter Info	[2], [3], [15]
D1700		Vinorelbine	C45H54N4O8	5311497	Moderate		Inter Info	[2], [3], [15]
D0425		Darolutamide	C19H19ClN6O2	67171867	Minor		Inter Info	[267]
D1104		Naloxegol	C34H53NO11	56959087	Minor		Inter Info	[271]
	Transporter induction					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1592		Tipranavir	C31H33F3N2O5S	54682461	Moderate		Inter Info	[15]
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 60
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0080		Amprenavir	C25H35N3O6S	65016	Major		Inter Info	[15]
D0116		Atazanavir	C38H52N6O7	148192	Major		Inter Info	[15]
D0192		Boceprevir	C27H45N5O5	10324367	Major		Inter Info	[15]
D0302		Ceritinib	C28H36ClN5O3S	57379345	Major		Inter Info	[15]
D0349		Clarithromycin	C38H69NO13	84029	Major		Inter Info	[15]
D0375		Cobicistat	C40H53N7O5S2	25151504	Major		Inter Info	[15]
D0439		Delavirdine	C22H28N6O3S	5625	Major		Inter Info	[15]
D0899		Lefamulin	C28H45NO5S	25185057	Major		Inter Info	[88]
D1653		Troleandomycin	C41H67NO15	202225	Major		Inter Info	[15]
D0789		Idelalisib	C22H18FN7O	11625818	Major		Inter Info	[15]
D0799		Indinavir	C36H47N5O4	5362440	Major		Inter Info	[15]
D0867		Itraconazole	C35H38Cl2N8O4	55283	Major		Inter Info	[15]
D0880		Ketoconazole	C26H28Cl2N4O4	456201	Major		Inter Info	[15]
D0946		Lonafarnib	C27H31Br2ClN4O2	148195	Major		Inter Info	[15]
D1117		Nefazodone	C25H32ClN5O2	4449	Major		Inter Info	[15]
D1119		Nelfinavir	C32H45N3O4S	64143	Major		Inter Info	[15]
D1315		Posaconazole	C37H42F2N8O4	468595	Major		Inter Info	[15]
D1415		Ritonavir	C37H48N6O5S2	392622	Major		Inter Info	[15]
D1541		Telaprevir	C36H53N7O6	3010818	Major		Inter Info	[15]
D1544		Telithromycin	C43H65N5O10	3002190	Major		Inter Info	[15]
D1660		Tucatinib	C26H24N8O2	51039094	Major		Inter Info	[15]
D0002		Abametapir (topical)	C12H12N2	15664	Moderate		Inter Info	[148]
D0069		Amlodipine	C20H25ClN2O5	2162	Moderate		Inter Info	[3], [15]
D0337		Cimetidine	C10H16N6S	2756	Moderate		Inter Info	[3], [15]
D0367		Clotrimazole	C22H17ClN2	2812	Moderate		Inter Info	[3], [15]
D0413		Dalfopristin	C34H50N4O9S	6323289	Moderate		Inter Info	[3], [15]
D0416		Danazol	C22H27NO2	28417	Moderate		Inter Info	[3], [15]
D0426		Darunavir	C27H37N3O7S	213039	Moderate		Inter Info	[3], [15]
D0497		Diltiazem	C22H26N2O4S	39186	Moderate		Inter Info	[3], [15]
D0543		Duvelisib	C22H17ClN6O	50905713	Moderate		Inter Info	[3], [15]
D0597		Erythromycin	C37H67NO13	12560	Moderate		Inter Info	[3], [15]
D0658		Fidaxomicin	C52H74Cl2O18	10034073	Moderate		Inter Info	[3], [15]
D0667		Fluconazole	C13H12F2N6O	3365	Moderate		Inter Info	[3], [15]
D0692		Fosamprenavir	C25H36N3O9PS	131536	Moderate		Inter Info	[3], [15]
D0693		Fosaprepitant	C23H22F7N4O6P	135413538	Moderate		Inter Info	[3], [15]
D0699		Fostamatinib	C23H26FN6O9P	11671467	Moderate		Inter Info	[3], [15]
D0171		Berotralstat	C30H26F4N6O	137528262	Moderate		Inter Info	[3], [15]
D0638		Fedratinib	C27H36N6O3S	16722836	Moderate		Inter Info	[3], [15]
D0735		Goldenseal	NA	NA	Moderate		Inter Info	[3], [15]
D0896		Larotrectinib	C21H22F2N6O2	46188928	Moderate		Inter Info	[3], [15]
D1709		Voxelotor	C19H19N3O3	71602803	Moderate		Inter Info	[3], [15]
D0793		Imatinib	C29H31N7O	5291	Moderate		Inter Info	[3], [15]
D0852		Isavuconazonium	C35H35F2N8O5S+	6918606	Moderate		Inter Info	[3], [15]
D0858		Isoniazid	C6H7N3O	3767	Moderate		Inter Info	[3], [15]
D0866		Istradefylline	C20H24N4O4	5311037	Moderate		Inter Info	[3], [15]
D0869		Ivacaftor	C24H28N2O3	16220172	Moderate		Inter Info	[3], [15]
D0891		Lanreotide	C54H69N11O10S2	71349	Moderate		Inter Info	[3], [15]
D0894		Lapatinib	C29H26ClFN4O4S	208908	Moderate		Inter Info	[3], [15]
D0901		Lemborexant	C22H20F2N4O2	56944144	Moderate		Inter Info	[3], [15]
D0911		Levamlodipine	C20H25ClN2O5	9822750	Moderate		Inter Info	[3], [15]
D1057		Miconazole	C18H14Cl4N2O	4189	Moderate		Inter Info	[3], [15]
D1163		Octreotide	C49H66N10O10S2	448601	Moderate		Inter Info	[3], [15]
D1214		Palbociclib	C24H29N7O2	5330286	Moderate		Inter Info	[3], [15]
D1383		Ranolazine	C24H33N3O4	56959	Moderate		Inter Info	[3], [15]
D1471		Simeprevir	C38H47N5O7S2	24873435	Moderate		Inter Info	[3], [15]
D1501		Spironolactone	C24H32O4S	5833	Moderate		Inter Info	[3], [15]
D1579		Ticagrelor	C23H28F2N6O4S	9871419	Moderate		Inter Info	[3], [15]
D1608		Tolvaptan	C26H25ClN2O3	216237	Moderate		Inter Info	[3], [15]
D1690		Verapamil	C27H38N2O4	2520	Moderate		Inter Info	[3], [15]
D1714		Zafirlukast	C31H33N3O6S	5717	Moderate		Inter Info	[3], [15]
	CYP450 enzyme induction					Drug Num: 37
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0095		Apalutamide	C21H15F4N5O2S	24872560	Major		Inter Info	[15]
D0255		Carbamazepine	C15H12N2O	2554	Major		Inter Info	[15]
D0697		Fosphenytoin	C16H15N2O6P	56339	Major		Inter Info	[15]
D0958		Lumacaftor	C24H18F2N2O5	16678941	Major		Inter Info	[110], [15]
D1283		Phenytoin	C15H12N2O2	1775	Major		Inter Info	[15]
D1401		Rifapentine	C47H64N4O12	135403821	Major		Inter Info	[15]
D1502		St. John's Wort	NA	NA	Major		Inter Info	[15]
D0061		Aminoglutethimide	C13H16N2O2	2145	Moderate		Inter Info	[15]
D0071		Amobarbital	C11H18N2O3	2164	Moderate		Inter Info	[15]
D0106		Armodafinil	C15H15NO2S	9690109	Moderate		Inter Info	[15]
D0194		Bosentan	C27H29N5O6S	104865	Moderate		Inter Info	[15]
D0224		Butabarbital	C10H16N2O3	2479	Moderate		Inter Info	[15]
D0225		Butalbital	C11H16N2O3	2481	Moderate		Inter Info	[15]
D0300		Cenobamate	C10H10ClN5O2	11962412	Moderate		Inter Info	[15]
D0406		Dabrafenib	C23H20F3N5O2S2	44462760	Moderate		Inter Info	[3], [211]
D0432		Deferasirox	C21H15N3O4	214348	Moderate		Inter Info	[15]
D0628		Etravirine	C20H15BrN6O	193962	Moderate		Inter Info	[15]
D0639		Felbamate	C11H14N2O4	3331	Moderate		Inter Info	[15]
D0601		Eslicarbazepine	C15H14N2O2	9881504	Moderate		Inter Info	[15]
D1538		Tazemetostat	C34H44N4O4	66558664	Moderate		Inter Info	[15]
D0732		Glycerol phenylbutyrate	C33H38O6	10482134	Moderate		Inter Info	[15]
D0741		Griseofulvin	C17H17ClO6	441140	Moderate		Inter Info	[15]
D0953		Lorlatinib	C21H19FN6O2	71731823	Moderate		Inter Info	[15]
D1040		Methylphenobarbital	C13H14N2O3	8271	Moderate		Inter Info	[237], [15], [238]
D1078		Mitotane	C14H10Cl4	4211	Moderate		Inter Info	[15]
D1099		Nafcillin	C21H22N2O5S	8982	Moderate		Inter Info	[15]
D1128		Nevirapine	C15H14N4O	4463	Moderate		Inter Info	[15]
D1186		Oritavancin	C86H97Cl3N10O26	16136912	Moderate		Inter Info	[15]
D1198		Oxcarbazepine	C15H12N2O2	34312	Moderate		Inter Info	[15]
D1248		Pentobarbital	C11H18N2O3	4737	Moderate		Inter Info	[15]
D1265		Phenobarbital	C12H12N2O3	4763	Moderate		Inter Info	[15]
D1274		Phenylbutazone	C19H20N2O2	4781	Moderate		Inter Info	[15]
D1340		Primidone	C12H14N2O2	4909	Moderate		Inter Info	[15]
D1433		Rufinamide	C10H8F2N4O	129228	Moderate		Inter Info	[15]
D1453		Secobarbital	C12H18N2O3	5193	Moderate		Inter Info	[15]
D1518		Sulfinpyrazone	C23H20N2O3S	5342	Moderate		Inter Info	[15]
D1652		Troglitazone	C24H27NO5S	5591	Moderate		Inter Info	[15]
Pharmacodynamic additive effects
	Additive CNS depression effects					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0452		Deutetrabenazine	C19H27NO3	73437646	Moderate		Inter Info	[221]
	Additive myelosuppressive effects					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0370		Clozapine	C18H19ClN4	135398737	Major		Inter Info	[46], [47]
	Increased risk of hepatotoxicity					Drug Num: 15
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1258		Pexidartinib	C20H15ClF3N5	25151352	Major		Inter Info	[91]
D0900		Leflunomide	C12H9F3N2O2	3899	Major		Inter Info	[1], [106], [107]
D0944		Lomitapide	C39H37F6N3O2	9853053	Major		Inter Info	[109]
D1073		Mipomersen	C230H324N67O122P19S19	118984467	Major		Inter Info	[124]
D1556		Teriflunomide	C12H9F3N2O2	54684141	Major		Inter Info	[1], [106], [107]
D0199		Brentuximab vedotin	NA	NA	Moderate		Inter Info	[206]
D0248		Cannabidiol	C21H30O2	644019	Moderate		Inter Info	[3], [207]
D1389		Remdesivir	C27H35N6O8P	121304016	Moderate		Inter Info	[2], [3], [222], [223], [224]
D0826		Interferon beta-1a	NA	NA	Moderate		Inter Info	[229], [230], [231], [232]
D0827		Interferon beta-1b	NA	NA	Moderate		Inter Info	[229], [230], [231], [232]
D1025		Methotrexate	C20H22N8O5	126941	Moderate		Inter Info	[3], [236]
D1106		Naltrexone	C20H23NO4	5360515	Moderate		Inter Info	[239]
D1239		Peginterferon beta-1a	NA	NA	Moderate		Inter Info	[229], [230], [231], [232]
D1589		Tioguanine	C5H5N5S	2723601	Moderate		Inter Info	[259], [260]
D1615		Trabectedin	C39H43N3O11S	108150	Moderate		Inter Info	[3], [261]
	Increased risk of prolong QT interval					Drug Num: 150
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0066		Amiodarone	C25H29I2NO3	2157	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0084		Anagrelide	C10H7Cl2N3O	135409400	Major		Inter Info	[1], [2], [3], [16]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Major		Inter Info	[19]
D0170		Bepridil	C24H34N2O	2351	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0320		Chloroquine	C18H26ClN3	2719	Major		Inter Info	[21], [3], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39]
D0342		Cisapride	C23H29ClFN3O4	6917698	Major		Inter Info	[1], [2], [3], [40], [41], [42]
D0345		Citalopram	C20H21FN2O	2771	Major		Inter Info	[1], [2], [3], [43], [44], [13], [45]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Major		Inter Info	[51]
D0508		Disopyramide	C21H29N3O	3114	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0513		Dofetilide	C19H27N3O5S2	71329	Major		Inter Info	[1], [2], [3], [52]
D0514		Dolasetron	C19H20N2O3	3033818	Major		Inter Info	[1], [2], [3], [53]
D0534		Dronedarone	C31H44N2O5S	208898	Major		Inter Info	[1], [2], [3], [54]
D0535		Droperidol	C22H22FN3O2	3168	Major		Inter Info	[1], [2], [3], [55], [56], [13]
D0554		Efavirenz	C14H9ClF3NO2	64139	Major		Inter Info	[60]
D0599		Escitalopram	C20H21FN2O	146570	Major		Inter Info	[1], [61], [2], [3], [62], [63], [13]
D0712		Gatifloxacin	C19H22FN3O4	5379	Major		Inter Info	[64], [65], [66], [1], [2], [3], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86]
D0872		Ivosidenib	C28H22ClF3N6O3	71657455	Major		Inter Info	[87]
D0965		Macimorelin	C26H30N6O3	9804938	Major		Inter Info	[89]
D0740		Grepafloxacin	C19H22FN3O3	72474	Major		Inter Info	[65], [1], [2], [3], [93], [94], [95]
D0749		Halofantrine	C26H30Cl2F3NO	37393	Major		Inter Info	[96], [1], [2], [3], [97], [98], [99], [100], [101]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Major		Inter Info	[21], [3], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39]
D0787		Ibutilide	C20H36N2O3S	60753	Major		Inter Info	[1], [2], [3], [102]
D0791		Iloperidone	C24H27FN2O4	71360	Major		Inter Info	[1], [2], [3], [103], [13]
D0909		Levacetylmethadol	C23H31NO2	15130	Major		Inter Info	[3], [108], [13]
D0960		Lumefantrine	C30H32Cl3NO	6437380	Major		Inter Info	[2], [3], [111]
D1010		Mesoridazine	C21H26N2OS2	4078	Major		Inter Info	[1], [2], [3], [112], [13]
D1017		Methadone	C21H27NO	4095	Major		Inter Info	[1], [2], [3], [113], [114], [115], [116], [117], [118], [119], [120], [121], [122], [13]
D1063		Mifepristone	C29H35NO2	55245	Major		Inter Info	[1], [2], [3], [123]
D1092		Moxifloxacin	C21H24FN3O4	152946	Major		Inter Info	[64], [65], [66], [1], [2], [3], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86]
D1190		Osimertinib	C28H33N7O2	71496458	Major		Inter Info	[125]
D1221		Panobinostat	C21H23N3O2	6918837	Major		Inter Info	[126]
D1223		Papaverine	C20H21NO4	4680	Major		Inter Info	[127], [128], [129], [130], [131], [132], [133], [134]
D1230		Pasireotide	C58H66N10O9	9941444	Major		Inter Info	[1], [2], [3], [135]
D1292		Pimozide	C28H29F2N3O	16362	Major		Inter Info	[3], [55], [136], [13]
D1343		Procainamide	C13H21N3O	4913	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1371		Quinidine	C20H24N2O2	441074	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1398		Ribociclib	C23H30N8O	44631912	Major		Inter Info	[1], [2], [3], [55], [71], [137], [138], [13]
D1498		Sotalol	C12H20N2O3S	5253	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D1499		Sparfloxacin	C19H22F2N4O3	60464	Major		Inter Info	[65], [1], [2], [3], [139], [140], [69], [71], [73], [141], [74], [75], [142], [77], [78], [79], [80], [143], [84], [95], [144]
D1612		Toremifene	C26H28ClNO	3005573	Major		Inter Info	[1], [2], [3], [145]
D1687		Vemurafenib	C23H18ClF2N3O3S	42611257	Major		Inter Info	[1], [2], [3], [146]
D1726		Ziprasidone	C21H21ClN4OS	60854	Major		Inter Info	[1], [2], [3], [55], [147], [13]
D0003		Abarelix	C72H95ClN14O14	16131215	Moderate		Inter Info	[3], [149], [150], [151], [152], [153], [154], [155]
D0007		Abiraterone	C24H31NO	132971	Moderate		Inter Info	[3], [149], [150], [151], [152], [153], [154], [155]
D0036		Alfuzosin	C19H27N5O4	2092	Moderate		Inter Info	[15]
D0068		Amitriptyline	C20H23N	2160	Moderate		Inter Info	[15]
D0072		Amoxapine	C17H16ClN3O	2170	Moderate		Inter Info	[15]
D0097		Apomorphine	C17H17NO2	6005	Moderate		Inter Info	[15]
D0105		Aripiprazole	C23H27Cl2N3O2	60795	Moderate		Inter Info	[2], [3], [196], [197], [198], [199], [200], [201]
D0112		Asenapine	C17H16ClNO	3036780	Moderate		Inter Info	[1], [2], [3], [202], [13]
D0115		Astemizole	C28H31FN4O	2247	Moderate		Inter Info	[15]
D0139		Azithromycin	C38H72N2O12	447043	Moderate		Inter Info	[15]
D0180		Bicalutamide	C18H14F4N2O4S	2375	Moderate		Inter Info	[3], [149], [150], [151], [152], [153], [154], [155]
D0195		Bosutinib	C26H29Cl2N5O3	5328940	Moderate		Inter Info	[15]
D0219		Buprenorphine	C29H41NO4	644073	Moderate		Inter Info	[15]
D0324		Chlorpromazine	C17H19ClN2S	2726	Moderate		Inter Info	[15]
D0336		Cilostazol	C20H27N5O2	2754	Moderate		Inter Info	[15]
D0341		Ciprofloxacin	C17H18FN3O3	2764	Moderate		Inter Info	[15]
D0358		Clofazimine	C27H22Cl2N4	2794	Moderate		Inter Info	[209]
D0361		Clomipramine	C19H23ClN2	2801	Moderate		Inter Info	[15]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Moderate		Inter Info	[15]
D0429		Daunorubicin	C27H29NO10	30323	Moderate		Inter Info	[15]
D0430		Daunorubicin (liposomal)	C27H29NO10	30323	Moderate		Inter Info	[15]
D0437		Degarelix	C82H103ClN18O16	16136245	Moderate		Inter Info	[3], [149], [150], [151], [152], [153], [154], [155]
D0446		Desipramine	C18H22N2	2995	Moderate		Inter Info	[15]
D0467		Dextropropoxyphene	C22H29NO2	10100	Moderate		Inter Info	[15]
D0525		Doxepin	C19H21NO	667477	Moderate		Inter Info	[15]
D0526		Doxepin (topical)	C19H21NO	667477	Moderate		Inter Info	[15]
D0528		Doxorubicin	C27H29NO11	31703	Moderate		Inter Info	[15]
D0529		Doxorubicin (liposomal)	C27H29NO11	31703	Moderate		Inter Info	[15]
D0577		Entrectinib	C31H34F2N6O2	25141092	Moderate		Inter Info	[2], [3], [215]
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Moderate		Inter Info	[3], [149], [150], [151], [152], [153], [154], [155]
D0584		Epirubicin	C27H29NO11	41867	Moderate		Inter Info	[15]
D0594		Eribulin	C40H59NO11	11354606	Moderate		Inter Info	[15]
D0636		Famotidine	C8H15N7O2S3	5702160	Moderate		Inter Info	[2], [3], [217]
D0664		Flecainide	C17H20F6N2O3	3356	Moderate		Inter Info	[15]
D0678		Fluphenazine	C22H26F3N3OS	3372	Moderate		Inter Info	[15]
D0694		Foscarnet	CH3O5P	3415	Moderate		Inter Info	[15]
D0700		Fostemsavir	C25H26N7O8P	11319217	Moderate		Inter Info	[15]
D0716		Gemifloxacin	C18H20FN5O4	9571107	Moderate		Inter Info	[15]
D0940		Lithium carbonate	CLi2O3	11125	Moderate		Inter Info	[15]
D1169		Oliceridine	C22H30N2O2S	66553195	Moderate		Inter Info	[15]
D1432		Rucaparib	C19H18FN3O	9931954	Moderate		Inter Info	[15]
D1634		Triclabendazole	C14H9Cl3N2OS	50248	Moderate		Inter Info	[15]
D0725		Glasdegib	C21H22N6O	25166913	Moderate		Inter Info	[227]
D0738		Granisetron	C18H24N4O	5284566	Moderate		Inter Info	[15]
D0751		Halothane	C2HBrClF3	3562	Moderate		Inter Info	[15]
D0758		Histrelin	C66H86N18O12	25077993	Moderate		Inter Info	[3], [149], [150], [151], [152], [153], [154], [155]
D0781		Hydroxyzine	C21H27ClN2O2	3658	Moderate		Inter Info	[15]
D0788		Idarubicin	C26H27NO9	42890	Moderate		Inter Info	[15]
D0795		Imipramine	C19H24N2	3696	Moderate		Inter Info	[15]
D0806		Inotuzumab ozogamicin	NA	NA	Moderate		Inter Info	[3], [228]
D0903		Lenvatinib	C21H19ClN4O4	9823820	Moderate		Inter Info	[15]
D0908		Leuprolide	C59H84N16O12	657181	Moderate		Inter Info	[3], [149], [150], [151], [152], [153], [154], [155]
D0919		Levofloxacin	C18H20FN3O4	149096	Moderate		Inter Info	[15]
D0937		Lisdexamfetamine	C15H25N3O	11597698	Moderate		Inter Info	[3]
D0942		Lofexidine	C11H12Cl2N2O	30668	Moderate		Inter Info	[15]
D0943		Lomefloxacin	C17H19F2N3O3	3948	Moderate		Inter Info	[15]
D0947		Loperamide	C29H33ClN2O2	3955	Moderate		Inter Info	[233], [234]
D0979		Maprotiline	C20H23N	4011	Moderate		Inter Info	[15]
D0992		Mefloquine	C17H16F6N2O	4046	Moderate		Inter Info	[15]
D1026		Methotrimeprazine	C19H24N2OS	72287	Moderate		Inter Info	[15]
D1062		Midostaurin	C35H30N4O4	9829523	Moderate		Inter Info	[15]
D1075		Mirtazapine	C17H19N3	4205	Moderate		Inter Info	[15]
D1137		Nilutamide	C12H10F3N3O4	4493	Moderate		Inter Info	[3], [149], [150], [151], [152], [153], [154], [155]
D1155		Norfloxacin	C16H18FN3O3	4539	Moderate		Inter Info	[15]
D1158		Nortriptyline	C19H21N	4543	Moderate		Inter Info	[15]
D1165		Ofloxacin	C18H20FN3O4	4583	Moderate		Inter Info	[15]
D1181		Ondansetron	C18H19N3O	4595	Moderate		Inter Info	[15]
D1189		Osilodrostat	C13H10FN3	44139752	Moderate		Inter Info	[15]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Moderate		Inter Info	[15]
D1210		Oxytocin	C43H66N12O12S2	439302	Moderate		Inter Info	[15]
D1215		Paliperidone	C23H27FN4O3	115237	Moderate		Inter Info	[15]
D1216		Palonosetron	C19H24N2O	6337614	Moderate		Inter Info	[15]
D1246		Pentamidine	C19H24N4O2	4735	Moderate		Inter Info	[15]
D1254		Perflutren	C3F8	6432	Moderate		Inter Info	[240], [241]
D1290		Pimavanserin	C25H34FN3O2	10071196	Moderate		Inter Info	[244]
D1339		Primaquine	C15H21N3O	4908	Moderate		Inter Info	[15]
D1342		Probucol	C31H48O2S2	4912	Moderate		Inter Info	[15]
D1346		Prochlorperazine	C20H24ClN3S	4917	Moderate		Inter Info	[15]
D1351		Promazine	C17H20N2S	4926	Moderate		Inter Info	[15]
D1352		Promethazine	C17H20N2S	4927	Moderate		Inter Info	[15]
D1353		Propafenone	C21H27NO3	4932	Moderate		Inter Info	[15]
D1356		Propofol	C12H18O	4943	Moderate		Inter Info	[245], [246], [247], [248], [249], [250], [251], [252], [253], [254]
D1361		Protriptyline	C19H21N	4976	Moderate		Inter Info	[15]
D1368		Quetiapine	C21H25N3O2S	5002	Moderate		Inter Info	[15]
D1372		Quinine	C20H24N2O2	3034034	Moderate		Inter Info	[15]
D1388		Relugolix	C29H27F2N7O5S	10348973	Moderate		Inter Info	[3], [149], [150], [151], [152], [153], [154], [155]
D1404		Rilpivirine	C22H18N6	6451164	Moderate		Inter Info	[15]
D1424		Romidepsin	C24H36N4O6S2	5352062	Moderate		Inter Info	[15]
D1491		Solifenacin	C23H26N2O2	154059	Moderate		Inter Info	[15]
D1497		Sorafenib	C21H16ClF3N4O3	216239	Moderate		Inter Info	[15]
D1522		Sunitinib	C22H27FN4O2	5329102	Moderate		Inter Info	[15]
D1526		Tacrolimus	C44H69NO12	445643	Moderate		Inter Info	[15]
D1533		Tamoxifen	C26H29NO	2733526	Moderate		Inter Info	[15]
D1542		Telavancin	C80H106Cl2N11O27P	3081362	Moderate		Inter Info	[15]
D1560		Tetrabenazine	C19H27NO3	6018	Moderate		Inter Info	[1], [2], [3], [257], [13]
D1596		Tizanidine	C9H8ClN5S	5487	Moderate		Inter Info	[15]
D1616		Tramadol	C16H25NO2	33741	Moderate		Inter Info	[15]
D1624		Trazodone	C19H22ClN5O	5533	Moderate		Inter Info	[262], [263], [196], [264], [265], [266], [13]
D1637		Trifluoperazine	C21H24F3N3S	5566	Moderate		Inter Info	[15]
D1638		Triflupromazine	C18H19F3N2S	5568	Moderate		Inter Info	[15]
D1647		Trimipramine	C20H26N2	5584	Moderate		Inter Info	[15]
D1651		Triptorelin	C64H82N18O13	25074470	Moderate		Inter Info	[3], [149], [150], [151], [152], [153], [154], [155]
D1673		Valbenazine	C24H38N2O4	24795069	Moderate		Inter Info	[15]
D1682		Vardenafil	C23H32N6O4S	135400189	Moderate		Inter Info	[15]
D1683		Vasopressin	C46H65N15O12S2	644077	Moderate		Inter Info	[15]
D1689		Venlafaxine	C17H27NO2	5656	Moderate		Inter Info	[15]
D1051		Metronidazole	C6H9N3O3	4173	Minor		Inter Info	[2], [268], [269], [270]
D1516		Sulfamethoxazole	C10H11N3O3S	5329	Minor		Inter Info	[1], [2], [3], [272], [273], [274], [275]
	Increased risk of ventricular arrhythmias					Drug Num: 36
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0067		Amisulpride	C17H27N3O4S	2159	Major		Inter Info	[14]
D0107		Arsenic trioxide	As2O3	14888	Major		Inter Info	[17], [18]
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[90]
D1474		Siponimod	C29H35F3N2O3	44599207	Major		Inter Info	[2], [92]
D0868		Ivabradine	C27H36N2O5	132999	Major		Inter Info	[3], [104], [105]
D0025		Adenosine	C10H13N5O4	60961	Moderate		Inter Info	[1], [156], [2], [3], [157], [158], [159], [40], [160], [161]
D0103		Arformoterol	C19H24N2O4	3083544	Moderate		Inter Info	[166], [167], [168], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195]
D0184		Bisacodyl	C22H19NO4	2391	Moderate		Inter Info	[1], [2], [3], [203], [204], [205]
D0269		Castor oil	C57H104O9	14030006	Moderate		Inter Info	[1], [2], [3], [203], [204], [205]
D0516		Donepezil	C24H29NO3	3152	Moderate		Inter Info	[1], [2], [3], [212], [213], [214]
D0691		Formoterol	C19H24N2O4	3410	Moderate		Inter Info	[166], [167], [168], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195]
D0887		Lactitol	C12H24O11	157355	Moderate		Inter Info	[1], [2], [3], [203], [204], [205]
D0924		Levosalbutamol	C13H21NO3	123600	Moderate		Inter Info	[179], [189], [192]
D0731		Glycerin	C3H8O3	753	Moderate		Inter Info	[1], [2], [3], [203], [204], [205]
D0797		Indacaterol	C24H28N2O3	6918554	Moderate		Inter Info	[166], [167], [168], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195]
D0854		Isoetharine	C13H21NO3	3762	Moderate		Inter Info	[166], [167], [168], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195]
D0859		Isoprenaline	C11H17NO3	3779	Moderate		Inter Info	[179], [189], [192]
D0970		Magnesium citrate	C12H10Mg3O14	6099959	Moderate		Inter Info	[1], [2], [3], [203], [204], [205]
D0973		Magnesium hydroxide	H2MgO2	14791	Moderate		Inter Info	[1], [2], [3], [203], [204], [205]
D1069		Mineral oil	NA	NA	Moderate		Inter Info	[1], [2], [3], [203], [204], [205]
D1171		Olodaterol	C21H26N2O5	11504295	Moderate		Inter Info	[166], [167], [168], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195]
D1185		Orciprenaline	C11H17NO3	4086	Moderate		Inter Info	[179], [189], [192]
D1266		Phenolphthalein	C20H14O4	4764	Moderate		Inter Info	[1], [2], [3], [203], [204], [205]
D1287		Picosulfuric acid	C18H15NO8S2	5243	Moderate		Inter Info	[3], [242], [243]
D1298		Pirbuterol	C12H20N2O3	4845	Moderate		Inter Info	[166], [167], [168], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195]
D1308		Polyethylene glycol (3350 with electrolytes)	C2H6O2	174	Moderate		Inter Info	[3], [242], [243]
D1309		Polyethylene glycol (3350)	C2H6O2	174	Moderate		Inter Info	[2], [3], [205]
D1414		Ritodrine	C17H21NO3	33572	Moderate		Inter Info	[166], [167], [168], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195]
D1418		Rivastigmine	C14H22N2O2	77991	Moderate		Inter Info	[1], [2], [3], [212], [213], [214]
D1438		Salbutamol	C13H21NO3	2083	Moderate		Inter Info	[179], [189], [192]
D1440		Salmeterol	C25H37NO4	5152	Moderate		Inter Info	[166], [167], [168], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195]
D1488		Sodium sulfate	Na2O4S	24436	Moderate		Inter Info	[3], [242], [243]
D1525		Tacrine	C13H14N2	1935	Moderate		Inter Info	[1], [2], [3], [212], [213], [214]
D1554		Terbutaline	C12H19NO3	5403	Moderate		Inter Info	[166], [167], [168], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195]
D1569		Thalidomide	C13H10N2O4	5426	Moderate		Inter Info	[2], [3], [258]
D1695		Vilanterol	C24H33Cl2NO5	10184665	Moderate		Inter Info	[179], [189], [192]
	Increased risk of other adverse reactions (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0178		Bexarotene	C24H28O2	82146	Major		Inter Info	[3], [20]
Pharmacodynamic antagonistic effects
	Antagonize the effect of serotonergic agents					Drug Num: 6
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0676		Fluoxetine	C17H18F3NO	3386	Moderate		Inter Info	[218], [15], [219]
D0687		Fluvoxamine	C15H21F3N2O2	5324346	Moderate		Inter Info	[218], [15], [219]
D1229		Paroxetine	C19H20FNO3	43815	Moderate		Inter Info	[218], [15], [219]
D1461		Sertraline	C17H17Cl2N	68617	Moderate		Inter Info	[218], [15], [219]
D1696		Vilazodone	C26H27N5O2	6918314	Moderate		Inter Info	[218], [15], [219]
D1708		Vortioxetine	C18H22N2S	9966051	Moderate		Inter Info	[218], [15], [219]

References
1	Canadian Pharmacists Association.
2	Cerner Multum, Inc. "Australian Product Information.".
3	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
4	Maxa JL, Hebeler RF, Adeeko MA "Torsades de pointes following concurrent amiodarone and levofloxacin therapy." Proc (Bayl Univ Med Cent) 19 (2006): 345-6. [PMID: 17106497]
5	Product Information. Betapace (sotalol). Berlex, Richmond, CA.
6	Product Information. Cordarone (amiodarone). Wyeth-Ayerst Laboratories, Philadelphia, PA.
7	Product Information. Norpace (disopyramide). Searle, Skokie, IL.
8	Product Information. Procan SR (procainamide). Parke-Davis, Morris Plains, NJ.
9	Product Information. Quiniglute (quinidine). Berlex, Richmond, CA.
10	Product Information. Vascor (bepridil). McNeil Pharmaceutical, Raritan, NJ.
11	Trujillo TC, Nolan PE "Antiarrhythmic agents - Drug interactions of clinical significance." Drug Safety 23 (2000): 509-32. [PMID: 11144659]
12	Yamreudeewong W, DeBisschop M, Martin L, Lower D "Potentially Significant Drug Interactions of Class III Antiarrhythmic Drugs." Drug Saf 26 (2003): 421-38. [PMID: 12688833]
13	EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
14	Product Information. Barhemsys (amisulpride). Acacia Pharma, Inc, Indianapolis, IN.
15	Product Information. Xospata (gilteritinib). Astellas Pharma US, Inc, Deerfield, IL.
16	Product Information. Agrylin (anagrelide). Roberts Pharmaceutical Corporation, Eatontown, NJ.
17	Ohnishi K, Yoshida H, Shigeno K, et al. "Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia." Ann Intern Med 133 (2000): 881-5. [PMID: 11103058]
18	Product Information. Trisenox (arsenic trioxide) Cephalon Inc, West Chester, PA.
19	Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
20	Product Information. Targretin (bexarotene) Ligand Pharmaceuticals, San Diego, CA.
21	Harper KM, Knapp DJ, Criswell HE, Breese GR "Vasopressin and alcohol: A multifaceted relationship." Psychopharmacology (Berl) 235 (2018): 3363-79. [PMID: 32936259]
22	Javelot H, El-Hage W, Meyer G, Becker G, Michel B, Hingray C "COVID-19 and (hydroxy)chloroquine-azithromycin combination: should we take the risk for our patients?" Br J Clin Pharmacol Apr 29 (2020): epub ahead of print. [PMID: 32350872]
23	National Institutes of Health (NIH) "Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.".
24	Product Information. Chloroquine Phosphate (chloroquine). West-Ward Pharmaceutical Corporation, Eatontown, NJ.
25	Product Information. Hydroxychloroquine Sulfate (hydroxychloroquine). Prasco Laboratories, Cincinnati, OH.
26	Product Information. Plaquenil (R). (hydroxychloroquine). Sanofi Winthrop Pharmaceuticals, New York, NY.
27	Roden DM, Harrington RA, Poppas A, Russo AM "Considerations for drug interactions on QTc in exploratory COVID-19 (Coroanvirus disease 2019) treatment." Heart Rhythm Apr 14 (2020): epub ahead of print. [PMID: 32302703]
28	Sacher F, Fauchier L, Boveda S, et.al "Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection." Arch Cardiovasc Dis Apr 24 (2020): epub ahead of print. [PMID: 32354666]
29	Saleh M, Gabriels J, ChangD, et.al "The effect of chloroquine, hydroxychloroquine and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection." Circ Arrhythm Electrophysiol Apr 29 (2020): epub ahead of print. [PMID: 32347743]
30	Sapp JL, Alqarawi W, MacIntyre CJ, et.al "Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of COVID-19: A statement from the Canadian Heart Rhythm Society." Can J Cardiol Apr 8 (2020): epub ahead of print. [PMID: 32299753]
31	Smit C, Peeters MYM, van den Anker JN, Knibbe CAJ "Chloroquine for SARS-CoV-2: Implications of its unique pharmacokinetic and safety properties." Clin Pharmacokinet Ar 18 (2020): epub ahead of print. [PMID: 32306288]
32	Bessiere F, Roccia H, Deliniere A, et.al "Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit." JAMA Cardiol May 1 (2020): epub ahead of print. [PMID: 32936266]
33	Borba MGS, Val FFA, Sampaio VS, et.al "Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 1 (SARS-CoV-2) infection: A randomized clinical trial." JAMA Netw Open Apr 1 (2020): epub ahead of print. [PMID: 32330277]
34	Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ "Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19)" Mayo Clin Proc Apr 7 (2020): epub ahead of print. [PMID: 32359771]
35	Kapoor A, Pandurangi U, Arora V, et.al "Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society." Indian Pacing Electorphysiol J Apr 8 (2020): epub ahead of print. [PMID: 32278018]
36	Mercuro NJ, Yen CF, Shim DJ, et.al "Risk of QT interval prolongation associated with the use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)" JAMA Cardiol May 1:e201834 (2020): epub ahead of print. [PMID: 32936252]
37	mitra RL, Greenstein SA, Epstein lm "An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin Possible benefits of intravenous lidocaine." HeartRythm Case Rep Apr 1 (2020): epub ahead of print. [PMID: 32363145]
38	US Food and Drug Administration "FACT SHEET FOR HEALTH CARE PROVIDERS EMERGENCY USE AUTHORIZATION (EUA) OF CHLOROQUINE PHOSPHATE SUPPLIED FROM THE STRATEGIC NATIONAL STOCKPILE FOR TREATMENT OF COVID-19 IN CERTAIN HOSPITALIZED PATIENTS. Available from: URL: https://www.fda.gov/media/13653" ([2020, Apr 27]):.
39	US Food and Drug Administration "Hydroxychloroquine or Chloroquine for COVID-19: Drug Safety Communication - FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems.".
40	Michalets EL, Williams CR "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet 39 (2000): 49-75. [PMID: 10926350]
41	Product Information. Propulsid (cisapride). Janssen Pharmaceutica, Titusville, NJ.
42	Trinkle R "Comment: syncopal episodes associated with cisapride." Ann Pharmacother 33 (1999): 251. [PMID: 10084425]
43	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide).".
44	Product Information. Celexa (citalopram). Forest Pharmaceuticals, St. Louis, MO.
45	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod).".
46	Product Information. Clozaril (clozapine). Novartis Pharmaceuticals, East Hanover, NJ.
47	Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
48	Garrouste C, Philipponnet C, Kaysi S, Enache I, Tiple A, Heng AE "Severe colchicine intoxication in a renal transplant recipient on cyclosporine." Transplant Proc 44 (2012): 2851-2. [PMID: 23146540]
49	Jonsson J, Gelpi JR, Light JA, Aquino A, Maszaros S "Colchicine-induced myoneuropathy in a renal transplant patient." Transplantation 53 (1992): 1369-71. [PMID: 1604496]
50	Kuncl RW, Duncan G, Watson D, et al "Colchicine myopathy and neuropathy." N Engl J Med 316 (1987): 1562-8. [PMID: 3035372]
51	Product Information. Xalkori (crizotinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
52	Product Information. Tikosyn (dofetilide) Pfizer US Pharmaceuticals, Atlanta, GA.
53	Product Information. Anzemet (dolasetron). Hoechst Marion-Roussel Inc, Kansas City, MO.
54	Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
55	Glassman AH, Bigger JT Jr "Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death." Am J Psychiatry 158 (2001): 1774-82. [PMID: 11691681]
56	Product Information. Inapsine (droperidol). Janssen Pharmaceutica, Titusville, NJ.
57	Mendell J, Zahir H, Matsushima N, et al. "Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor." Am J Cardiovasc Drugs (2013):. [PMID: 23784266]
58	Parasrampuria DA, Mendell J, Shi M, Matsushima N, Zahir H, Truitt K "Edoxaban drug-drug interactions with ketoconazole, erythromycin, and cyclosporine." Br J Clin Pharmacol 0 (2016): epub. [PMID: 27530188]
59	Product Information. Savaysa (edoxaban). Daiichi Sankyo, Inc., Parsippany, NJ.
60	Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
61	Castro VM, Clements CC, Murphy SN, et al. "QT interval and antidepressant use: a cross sectional study of electronic health records." BMJ 346 (2013): f288. [PMID: 23360890]
62	Do A, Noohi S, Elie D, et al. Health Canada Warning on Citalopram and Escitalopram--Its Effects on Prescribing in Consultation-Liaison Psychiatry.?Psychosomatics. 2016;57(1):57-63. [PMID: 26633294]
63	Product Information. Lexapro (escitalopram). Forest Pharmaceuticals, St. Louis, MO.
64	Ansari SR, Chopra N "Gatifloxacin and Prolonged QT Interval." Am J Med Sci 327 (2004): 55-6. [PMID: 14722399]
65	Ball P "Quinolone-induced QT interval prolongation: a not-so-unexpected class effect." J Antimicrob Chemother 45 (2000): 557-9. [PMID: 10797074]
66	Bertino JS Jr, Owens RC Jr, Carnes TD, Iannini PB "Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors." Clin Infect Dis 34 (2002): 861-3. [PMID: 11830802]
67	Dale KM, Lertsburapa K, Kluger J, White CM "Moxifloxacin and torsade de pointes." Ann Pharmacother 41 (2007): 336-40. [PMID: 17284508]
68	Demolis JL, Kubitza D, Tenneze L, Funck-Bretano C "Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects." Clin Pharmacol Ther 68 (2000): 658-66. [PMID: 11180026]
69	Falagas ME, Rafailidis PI, Rosmarakis ES "Arrhythmias associated with fluoroquinolone therapy." Int J Antimicrob Agents 29 (2007): 374-9. [PMID: 17241772]
70	Frothingham R "Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin." Pharmacotherapy 21 (2001): 1468-72. [PMID: 11765299]
71	Iannini PB "Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval." Expert Opin Drug Saf 1 (2002): 121-8. [PMID: 12904146]
72	Iannini PB, Circiumaru I "Gatifloxacin-induced QTc prolongation and ventricular tachycardia." Pharmacotherapy 21 (2001): 361-2. [PMID: 11253862]
73	Iannini PB, Doddamani S, Byazrova E, Curciumaru I, Kramer H "Risk of torsades de pointes with non-cardiac drugs." BMJ 322 (2001): 46-7. [PMID: 11141163]
74	Kang J, Wang L, Chen XL, Triggle DJ, Rampe D "Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG." Mol Pharmacol 59 (2001): 122-6. [PMID: 11125032]
75	Katritsis D, Camm AJ "Quinolones: cardioprotective or cardiotoxic." Pacing Clin Electrophysiol 26 (2003): 2317-20. [PMID: 14675020]
76	Noel GJ, Natarajan J, Chien S, Hunt TL, Goodman DB, Abels R "Effects of three fluoroquinolones on QT interval in healthy adults after single doses." Clin Pharmacol Ther 73 (2003): 292-303. [PMID: 12709719]
77	Oliphant CM, Green GM "Quinolones: a comprehensive review." Am Fam Physician 65 (2002): 455-64. [PMID: 11858629]
78	Owens RC "QT Prolongation with Antimicrobial Agents : Understanding the Significance." Drugs 64 (2004): 1091-124. [PMID: 15139788]
79	Owens RC "Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes." Pharmacotherapy 21 (2001): 301-19. [PMID: 11253855]
80	Owens RC Jr, Ambrose PG "Torsades de pointes associated with fluoroquinolones." Pharmacotherapy 22 (2002): 663-8 discussion 668-72. [PMID: 12013370]
81	Product Information. Avelox (moxifloxacin) Bayer, West Haven, CT.
82	Product Information. Tequin (gatifloxacin) Bristol-Myers Squibb, Princeton, NJ.
83	Siepmann M, Kirch W "Drug points - Tachycardia associated with moxifloxacin." Br Med J 322 (2001): 23. [PMID: 11141146]
84	Stahlmann R "Clinical toxicological aspects of fluoroquinolones." Toxicol Lett 127 (2002): 269-77. [PMID: 12052667]
85	Tsikouris JP, Peeters MJ, Cox CD, Meyerrose GE, Seifert CF "Effects of three fluoroquinolones on QT analysis after standard treatment courses." Ann Noninvasive Electrocardiol 11 (2006): 52-6. [PMID: 16472283]
86	White CM, Grant EM, Quintiliani R "Moxifloxacin does increase the corrected QT interval." Clin Infect Dis 33 (2001): 1441-2. [PMID: 11565091]
87	Product Information. Tibsovo (ivosidenib). Agios Pharmaceuticals, Cambridge, MA.
88	Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
89	Product Information. Macrilen (macimorelin). Aeterna Zentaris, Charleston, SC.
90	Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
91	Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
92	Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
93	Lode H, Vogel F, Elies W "Grepafloxacin: A review of its safety profile based on clinical trials and postmarketing surveillance." Clin Ther 21 (1999): 61-74. [PMID: 10090425]
94	Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
95	Thomas M, Maconochie JG, Fletcher E "The dilemma of the prolonged QT interval in early drug studies." Br J Clin Pharmacol 41 (1996): 77-81. [PMID: 8838432]
96	Abernethy DR, Wesche DL, Barbey JT, et al. "Stereoselective halofantrine disposition and effect: concentration-related QTc prolongation." Br J Clin Pharmacol 51 (2001): 231-7. [PMID: 11298069]
97	Giao PT, de Vries PJ "Pharmacokinetic interactions of antimalarial agents." Clin Pharmacokinet 40 (2001): 343-73. [PMID: 11432537]
98	Nosten F, ter Kuile FO, Luxemburger C, et al "Cardiac effects of antimalarial treatment with halofantrine." Lancet 341 (1993): 1054-6. [PMID: 8096959]
99	Product Information. Halfan (halofantrine). GlaxoSmithKline, Philadelphia, PA.
100	Product Information. Lariam (mefloquine). Roche Laboratories, Nutley, NJ.
101	Sudden death in a traveler following halofantrine administration--Togo, 2000. MMWR Morb Mortal Wkly Rep 50 (2001): 169-70, 179. [PMID: 11393488]
102	Product Information. Corvert (ibutilide). Pharmacia and Upjohn, Kalamazoo, MI.
103	Product Information. Exforge HCT (amlodipine/hydrochlorothiazide/valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
104	Mittal SR "Slow junctional rhythm, QTc prolongation and transient torsades de-pointes following combined use of Ivabradine, Diltiazem and Ranolazine." J Assoc Physicians India 62 (2014): 426-7. [PMID: 25438492]
105	Product Information. Corlanor (ivabradine). Amgen USA, Thousand Oaks, CA.
106	EMEA "EMEA public statement on leflunomide (ARAVA) - severe and serious hepatic reactions.".
107	Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
108	Product Information. Orlaam (levomethadyl acetate) Roxanne Laboratories Inc, Columbus, OH.
109	Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
110	Patel S, Robinson R, Burk M "Hypertensive crisis associated with St. John's Wort." Am J Med 112 (2002): 507-8. [PMID: 11959071]
111	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
112	Product Information. Serentil (mesoridazine) Boehringer-Ingelheim, Ridgefield, CT.
113	De Bels D, Staroukine M, Devriendt J "Torsades de pointes due to methadone." Ann Intern Med 139 (2003): E156. [PMID: 12859181]
114	Ehret GB, Desmeules JA, Broers B "Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology." Expert Opin Drug Saf 6 (2007): 289-303. [PMID: 17480178]
115	Gil M, Sala M, Anguera I, et al. "QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone." Am J Cardiol 92 (2003): 995-7. [PMID: 14556883]
116	Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS "Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes." Pharmacotherapy 23 (2003): 802-5. [PMID: 12820821]
117	Krantz MJ, Lewkowiez L, Hays H, et al "Torsade de pointes associated with very-high-dose methadone." Ann Intern Med 137 (2002): 501-4. [PMID: 12230351]
118	Krantz MJ, Mehler PS "Synthetic opioids and QT prolongation." Arch Intern Med 163 (2003): 1615 author reply 1615. [PMID: 12860589]
119	Martell BA, Arnsten JH, Krantz MJ, Gourevitch MN "Impact of methadone treatment on cardiac repolarization and conduction in opioid users." Am J Cardiol 95 (2005): 915-8. [PMID: 15781034]
120	Mokwe EO, Ositadinma O "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966000]
121	Sala M, Anguera I, Cervantes M "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966001]
122	Walker PW, Klein D, Kasza L "High dose methadone and ventricular arrhythmias: a report of three cases." Pain 103 (2003): 321-4. [PMID: 12791438]
123	Product Information. Korlym (mifepristone). Corcept Therapeutics Incorporated, Menlo Park, CA.
124	Product Information. Kynamro (mipomersen). Genzyme Corporation, Cambridge, MA.
125	Product Information. Tagrisso (osimertinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
126	Product Information. Farydak (panobinostat). Novartis Pharmaceuticals, East Hanover, NJ.
127	Goto M, Sato M, Kitzazawa H, et.al "Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation." Intern Med 53 (2014): 1629-31. [PMID: 25088875]
128	Inoue T, Asahi S, Takayanagi K, Morooka S, Takabatake Y "QT prolongation and possibility of ventricular arrhythmias after intracoronary papaverine." Cardiology 84 (1994): 9-13. [PMID: 7511988]
129	Jain A, Jenkins MG "Intracoronary electrocardiogram during torsade des pointes secondary to intracoronary papaverine." Cathet Cardiovasc Diagn 18 (1989): 255-7. [PMID: 2605630]
130	Kern MJ, Deligonul U, Serota H, Gudipati C, Buckingham T "Ventricular arrhythmia due to intracoronary papaverine: analysis of QT intervals and coronary vasodilatory reserve." Cathet Cardiovasc Diagn 19 (1990): 229-36. [PMID: 2334953]
131	Nakayama M, Saito A, Kitazawa H, et.al "Papaverine-induced polymorphic ventricular tachycardia in relation to QTU and giant T-U waves in four cases." Intern Med 51 (2012): 351-6. [PMID: 22333368]
132	Nakayama M, Tanaka N, Sakoda K, et.al "Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease." Circ J 79 (2015): 530-6. [PMID: 25746536]
133	Talman CL, Winniford MD, Rossen JD, Simonetti I, Kienzle MG, Marcus ML "Polymorphous ventricular tachycardia: a side effect of intracoronary papaverine." J Am Coll Cardiol 15 (1990): 275-8. [PMID: 2299067]
134	Vrolix M, Piessens J, De Geest H "Torsades de pointes after intracoronary papaverine." Eur Heart J 12 (1991): 273-6. [PMID: 2044564]
135	Product Information. Signifor (pasireotide). Novartis Pharmaceuticals, East Hanover, NJ.
136	Product Information. Orap Tablets (pimozide). Gate Pharmaceuticals, Sellersville, PA.
137	Product Information. Kisqali (ribociclib). Novartis Pharmaceuticals, East Hanover, NJ.
138	Witchel HJ, Hancox JC, Nutt DJ "Psychotropic drugs, cardiac arrhythmia, and sudden death." J Clin Psychopharmacol 23 (2003): 58-77. [PMID: 12544377]
139	Demolis JL, Charransol A, Funck-Brentano C, Jaillon P "Effects of a single oral dose of sparfloxacin on ventricular repolarization in healthy volunteers." Br J Clin Pharmacol 41 (1996): 499-503. [PMID: 8799513]
140	Dupont H, Timsit JF, Souweine B, Gachot B, Wolff M, Regnier B "Torsades de pointe probably related to sparfloxacin." Eur J Clin Microbiol Infect Dis 15 (1996): 350-1. [PMID: 8781892]
141	Jaillon P, Morganroth J, Brumpt I, Talbot G "Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group." J Antimicrob Chemother 37(suppl a) (1996): 161-7. [PMID: 8737135]
142	Lipsky BA, Dorr MB, Magner DJ, Talbot GH "Safety profile of sparfloxacin, a new fluoroquinolone antibiotic." Clin Ther 21 (1999): 148-59. [PMID: 10090432]
143	Product Information. Zagam (sparfloxacin). Rhone-Poulenc Rorer, Collegeville, PA.
144	Zix JA, GeerdesFenge HF, Rau M, Vockler J, Borner K, Koeppe P, Lode H "Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate." Antimicrob Agents Chemother 41 (1997): 1668-72. [PMID: 9257738]
145	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
146	Product Information. Zelboraf (vemurafenib). Genentech, South San Francisco, CA.
147	Product Information. Geodon (ziprasidone). Pfizer US Pharmaceuticals, New York, NY.
148	Product Information. Xeglyze (abametapir topical). Dr. Reddy's Laboratories Inc, Upper Saddle River, NJ.
149	Product Information. Eligard (leuprolide). Sanofi Winthrop Pharmaceuticals, New York, NY.
150	Product Information. Firmagon (degarelix). Ferring Pharmaceuticals Inc, Tarrytown, NY.
151	Product Information. Lupron (leuprolide). TAP Pharmaceuticals Inc, Deerfield, IL.
152	Product Information. Plenaxis (abarelix). Praecis Pharmaceuticals Inc, Waltham, MA.
153	Product Information. Trelstar (triptorelin) Pharmacia and Upjohn, Kalamazoo, MI.
154	Product Information. Vantas (histrelin). Endo Pharmaceuticals (formally Indevus Pharmaceuticals Inc), Lexington, MA.
155	Product Information. Zoladex (goserelin). Zeneca Pharmaceuticals, Wilmington, DE.
156	Celiker A, Tokel K, Cil E, Ozkutlu S, Ozme S "Adenosine induced torsades de pointes in a child with congenital long QT syndrome." Pacing Clin Electrophysiol 17 (1994): 1814-7. [PMID: 7838793]
157	Teodorovich N, Margolin E, Kogan Y, Paz O, Swissa M. Torsades de pointes after adenosine administration. J Electrocardiol. 2016;49(2):171-173. [PMID: 26850499]
158	Harrington GR, Froelich EG "Adenosine-induced torsades de pointes." Chest 103 (1993): 1299-1301. [PMID: 8131497]
159	Mallet ML "Proarrhythmic effects of adenosine: a review of the literature." Emerg Med J 21 (2004): 408-10. [PMID: 15208219]
160	Tachakra SS, Robinson S "Adenosine and cardiac arrhythmias." BMJ 305 (1992): 422. [PMID: 1392935]
161	Wesley RC Jr, Turnquest P "Torsades de pointe after intravenous adenosine in the presence of prolonged QT syndrome." Am Heart J 123 (1992): 794-6. [PMID: 1539535]
162	Product Information. Tekturna (aliskiren). Novartis Pharmaceuticals, East Hanover, NJ.
163	Tapaninen T, Backman JT, Kurkinen K, Neuvonen P, Niemi M "Itraconazole, a P-glycoprotein and CYP3A4 inhibitor, markedly raises the plasma concentrations and enhances the renin-inhibiting effect of aliskiren." J Clin Pharmacol 51 (2011): 359-67. [PMID: 20400651]
164	Product Information. Eliquis (apixaban). Bristol-Myers Squibb Canada Inc, Montreal, IN.
165	Product Information. Qelbree (viloxazine). Supernus Pharmaceuticals Inc, Rockville, MD.
166	Bengtsson B, Fagerstrom PO "Extrapulmonary effects of terbutaline during prolonged administration." Clin Pharmacol Ther 31 (1982): 726-32. [PMID: 7042176]
167	Braden GL, vonOeyen PT, Germain MJ, Watson DJ, Haag BL "Ritodrine- and terbutaline-induced hypokalemia in preterm labor: Mechanisms and consequences." Kidney Int 51 (1997): 1867-75. [PMID: 9186877]
168	Clifton GD, Hunt BA, Patel RC, Burki NK "Effects of sequential doses of parenteral terbutaline on plasma levels of potassium and related cardiopulmonary responses." Am Rev Respir Dis 141 (1990): 575-9. [PMID: 2178522]
169	Dickens GR, Mccoy RA, West R, Stapczynski JS, Clifton GD "Effect of nebulized albuterol on serum potassium and cardiac rhythm in patients with asthma or chronic obstructive pulmonary disease." Pharmacotherapy 14 (1994): 729-33. [PMID: 7885977]
170	Ferguson GT, Funck-Brentano C, Fischer T, Darken P, Reisner C "Cardiovascular Safety of Salmeterol in COPD." Chest 123 (2003): 1817-24. [PMID: 12796155]
171	Gelmont DM, Balmes JR, Yee A "Hypokalemia induced by inhaled bronchodilators." Chest 94 (1988): 763-6. [PMID: 3168573]
172	Gross TL, Sokol RJ "Severe hypokalemia and acidosis: a potential complication of beta- adrenergic treatment." Am J Obstet Gynecol 138 (1980): 1225-6. [PMID: 7446635]
173	Hastwell G, Lambert BE "The effect of oral salbutamol on serum potassium and blood sugar." Br J Obstet Gynaecol 85 (1978): 767-9. [PMID: 708661]
174	Hurlbert BJ, Edelman JD, David K "Serum potassium levels during and after terbutaline." Anesth Analg 60 (1981): 723-5. [PMID: 7197475]
175	Hypokalaemia due to salbutamol overdosage. Br Med J (Clin Res Ed) 283 (1981): 500-1. [PMID: 6114774]
176	Kantola I, Tarssanen L "Hypokalemia from usual salbutamol dosage ." Chest 89 (1986): 619-20. [PMID: 3956296]
177	Lowe MD, Rowland E, Brown MJ, Grace AA "Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium." Heart 86 (2001): 45-51. [PMID: 11410561]
178	Milic M, Bao X, Rizos D, Liu F, Ziegler MG "Literature review and pilot studies of the effect of qt correction formulas on reported beta(2)-agonist-induced QTc prolongation." Clin Ther 28 (2006): 582-90. [PMID: 16750469]
179	Product Information. Arcapta Neohaler (indacaterol). Novartis Pharmaceuticals, East Hanover, NJ.
180	Product Information. Breo Ellipta (fluticasone-vilanterol). GlaxoSmithKline, Research Triangle Park, NC.
181	Product Information. Brovana (arformoterol). Sepracor Inc, Marlborough, MA.
182	Product Information. Foradil (formoterol) Novartis Pharmaceuticals, East Hanover, NJ.
183	Product Information. Maxair (pirbuterol). 3M Pharmaceuticals, St. Paul, MN.
184	Product Information. Proventil (albuterol). Schering Laboratories, Kenilworth, NJ.
185	Product Information. Severent (salmeterol). Glaxo Wellcome, Research Triangle Park, NC.
186	Product Information. Striverdi Respimat (olodaterol). Boehringer Ingelheim, Ridgefield, CT.
187	Product Information. Xopenex (levalbuterol). Sepracor, Marlborough, MA.
188	Rakhmanina NY, Kearns GL, Farrar HC "Hypokalemia in an asthmatic child from abuse of albuterol metered dose inhaler." Pediatr Emerg Care 14 (1998): 145-7. [PMID: 9583400]
189	Sanders JP, Potter DE, Ellis S, Bee DE, Grant JA "Metabolic and cardiovascular effects of carbuterol and metaproterenol." J Allergy Clin Immunol 60 (1977): 174-9. [PMID: 19514]
190	Sun ZH, Swan H, Vitasalo M, Toivonen L "Effects of epinephrine and phenylephrine on QT interval dispersion in congenital long QT syndrome." J Am Coll Cardiol 31 (1998): 1400-5. [PMID: 9581741]
191	Tveskov C, Djurhuus MS, Klitgaard NAH, Egstrup K "Potassium and magnesium distribution, ECG changes, and ventricular ectopic beats during beta(2)-adrenergic stimulation with terbutaline in healthy subjects." Chest 106 (1994): 1654-9. [PMID: 7988180]
192	Whyte KF, Addis GJ, Whitesmith R, Reid JL "The mechanism of salbutamol-induced hypokalaemia." Br J Clin Pharmacol 23 (1987): 65-71. [PMID: 3545273]
193	Windom H, Grainger J, Burgess C, Crane J, Pearce N, Beasley R "A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol." N Z Med J 103 (1990): 259-61. [PMID: 1972557]
194	Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE "Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma." Lancet 336 (1990): 1396-9. [PMID: 1978872]
195	Larsson S, Svedmyr N "Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol inasthmatics." Am Rev Respir Dis 116 (1977): 861-9. [PMID: 921062]
196	Goodnick PJ, Jerry J, Parra F "Psychotropic drugs and the ECG: focus on the QTc interval." Expert Opin Pharmacother 3 (2002): 479-98. [PMID: 11996627]
197	Kane JM, Carson WH, Saha AR, et al. "Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder." J Clin Psychiatry 63 (2002): 763-71. [PMID: 12363115]
198	Keck PE Jr, Marcus R, Tourkodimitris S, et al. "A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania." Am J Psychiatry 160 (2003): 1651-8. [PMID: 12944341]
199	Nelson S, Leung JG "Torsades de Pointes After Administration of Low-Dose Aripiprazole (February)." Ann Pharmacother (2013):. [PMID: 23362038]
200	Pigott TA, Carson WH, Saha AR, Torbeyns AF, Stock EG, Ingenito GG "Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study." J Clin Psychiatry 64 (2003): 1048-56. [PMID: 14628980]
201	Product Information. Abilify (aripiprazole). Bristol-Myers Squibb, Princeton, NJ.
202	Product Information. Saphris (asenapine). Schering-Plough Corporation, Kenilworth, NJ.
203	Chin RL "Laxative-induced hypokalemia." Ann Emerg Med 32 (1998): 517-8. [PMID: 9774942]
204	Muller-Lissner SA "Adverse effects of laxatives: fact and fiction." Pharmacology 47 (1993): 138-45. [PMID: 8234421]
205	Schaefer DC, Cheskin LJ "Constipation in the elderly." Am Fam Physician 58 (1998): 907-14. [PMID: 9767726]
206	Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
207	Product Information. Epidiolex (cannabidiol). Greenwich Biosciences Inc, Carlsbad, CA.
208	Product Information. Tabrecta (capmatinib). Novartis Pharmaceuticals, East Hanover, NJ.
209	Product Information. Lamprene (clofazimine). Novartis Pharmaceuticals, East Hanover, NJ.
210	Product Information. Cotellic (cobimetinib). Genentech, South San Francisco, CA.
211	Product Information. Tafinlar (dabrafenib). GlaxoSmithKline, Research Triangle Park, NC.
212	Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
213	Product Information. Exelon (rivastigmine) Novartis Pharmaceuticals, East Hanover, NJ.
214	Product Information. Razadyne (galantamine). Johnson and Johnson Medical Inc, Arlington, TX.
215	Product Information. Rozlytrek (entrectinib). Genentech, South San Francisco, CA.
216	Product Information. Afinitor (everolimus). Novartis Pharmaceuticals, East Hanover, NJ.
217	Product Information. Pepcid (famotidine). Merck & Co, Inc, West Point, PA.
218	Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.
219	Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7. [PMID: 3725002]
220	Product Information. Bevyxxa (betrixaban). Portola Pharmaceuticals, South San Francisco, CA.
221	Product Information. Austedo (deutetrabenazine). Teva Pharmaceuticals USA, North Wales, PA.
222	European Medicines Agency "Summary on compassionate use. Remdesivir Gilead.".
223	Gilead Sciences, Inc "About Remdesivir.".
224	US Food and Drug Administration "Fact sheet for health care providers emergency use authorization (EUA) of remdesivir (GS-5734TM)".
225	Product Information. Nurtec ODT (rimegepant). Biohaven Pharmaceuticals, New Haven, CT.
226	Product Information. Ubrelvy (ubrogepant). Allergan Inc, Irvine, CA.
227	Product Information. Daurismo (glasdegib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
228	Product Information. Besponsa (inotuzumab ozogamicin). Wyeth Laboratories, Philadelphia, PA.
229	Product Information. Avonex (interferon beta-1a). Biogen, Cambridge, MA.
230	Product Information. Betaseron (interferon beta-1b). Berlex, Richmond, CA.
231	Product Information. Plegridy (peginterferon beta-1a). Biogen Idec Inc, Cambridge, MA.
232	Product Information. Rebif (interferon beta-1a). Serono Laboratories Inc, Norwell, MA.
233	Eggleston W, Clark KH, Marraffa JM "Loperamide abuse associated with cardiac dysrhythmia and death." Ann Emerg Med 69 (2017): 83-6. [PMID: 27140747]
234	US Food and Drug Administration "FDA warns about serious heart problems with high doses of the antidiarrheal medicine loperamide (Imodium), including from abuse and misuse.".
235	Product Information. Selzentry (maraviroc). Pfizer U.S. Pharmaceuticals Group, New York, NY.
236	Product Information. Methotrexate (methotrexate). Lederle Laboratories, Wayne, NJ.
237	Product Information. Diabinese (chlorpropamide). Pfizer US Pharmaceuticals, New York, NY.
238	Skillman TG, Feldman JM "The pharmacology of sulfonylureas." Am J Med 70 (1981): 361-72. [PMID: 6781341]
239	Product Information. ReVia (naltrexone). DuPont Pharmaceuticals, Wilmington, DE.
240	Product Information. Definity (perflutren). Lantheus Medical Imaging Inc, North Billerica, MA.
241	Product Information. Optison (perflutren). Mallinckrodt Medical Inc, St. Louis, MO.
242	Product Information. Suclear (polyethylene glycol 3350 with electrolytes). Braintree Laboratories, Braintree, MA.
243	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
244	Product Information. Nuplazid (pimavanserin). Accelis Pharma, East Windsor, NJ.
245	Hanci V, Aydin M, Yurtlu BS, et.al "Anesthesia induction with sevoflurane and propofol: evaluation of P-wave dispersion, QT and corrected QT intervals." Kaohsiung J Med Sci 26 (2010): 470-7. [PMID: 20837343]
246	Kim DH, Kweon TD, Nam SB, Han DW, Cho WY, Lee JS "Effects of target concentration infusion of propofol and tracheal intubation on QTc interval." Anaesthesia 63 (2008): 1061-4. [PMID: 18717665]
247	Kleinsasser A, Kuenszberg E, Loeckinger A, et.al "Sevoflurane, but not propofol, significantly prolongs the Q-T interval." Anesth Analg 90 (2000): 25-7. [PMID: 10624970]
248	Kleinsasser A, Loeckinger A, Lindner KH, Keller C, Boehler M, Puehringer F "Reversing sevoflurane-associated Q-Tc prolongation by changing to propofol." Anaesthesia 56 (2001): 248-50. [PMID: 11251432]
249	Paventi S, Santevecchi A, Ranieri R "Effects of sevoflurane versus propofol on QT interval." Minerva Anestesiol 67 (2001): 637-40. [PMID: 11731753]
250	Scalese MJ, Herring HR, Rathburn RC, Skrepnek GH, Ripley TL "Propofol-associated QTc prolongation." Ther Adv Drug Saf 7 (2016): 68-78. [PMID: 27298717]
251	Staikou C, Stamelos M, Stavroulakis E "Impact of anaesthetic drugs and adjuvants on ECG markers of torsadogenicity." Br J Anaesth 112 (2014): 217-30. [PMID: 24305646]
252	Toyoda T, Terao Y, Oji M, Okada M, Fukusaki M, Sumikawa K "The interaction of antiemetic dose of droperidol with propofol on QT interval during anesthetic induction." J Anesth 27 (2013): 885-9. [PMID: 23660990]
253	Whyte SD, Booker PD, Buckley DG "The Effects of Propofol and Sevoflurane on the QT Interval and Transmural Dispersion of Repolarization in Children." Anesth Analg 100 (2005): 71-77. [PMID: 15616054]
254	Wutzler A, De Asmundis C, Matsuda H, et.al "Effects of propofol on ventricular repolarization and incidence of malignant arrhythmias in adults." J Electrocardiol 51 (2018): 170-4. [PMID: 29174097]
255	Product Information. Varubi (rolapitant). Tesaro Inc., Waltham, MA.
256	Product Information. Talzenna (talazoparib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
257	Product Information. Xenazine (tetrabenazine). Prestwick Pharmaceuticals Inc, Washington DC, VA.
258	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
259	Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
260	Product Information. Tabloid (thioguanine). Prasco Laboratories, Cincinnati, OH.
261	Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.
262	Antonelli D, Atar S, Freedberg NA, Rosenfeld T "Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions." Isr Med Assoc J 7 (2005): 163-5. [PMID: 15792261]
263	Dattilo PB, Nordin C "Prolonged QT associated with an overdose of trazodone." J Clin Psychiatry 68 (2007): 1309-10. [PMID: 17854263]
264	Levenson JL "Prolonged QT interval after trazodone overdose." Am J Psychiatry 156 (1999): 969-70. [PMID: 10360146]
265	Mazur A, Strasberg B, Kusniec J, Sclarovsky S "QT prolongation and polymorphous ventricular tachycardia associated with trasodone-amiodarone combination." Int J Cardiol 52 (1995): 27-9. [PMID: 8707432]
266	Product Information. Oleptro (traZODone). Labopharm Inc, Laval, AL.
267	Product Information. Nubeqa (darolutamide). Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ.
268	Kounas SP, Letsas KP, Sideris A, Efraimidis M, Kardaras F "QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone." Pacing Clin Electrophysiol 28 (2005): 472-3. [PMID: 15869686]
269	Product Information. Flagyl (metronidazole). Searle, Skokie, IL.
270	Product Information. Pylera (bismuth subcitrate potassium/metronidazo/TCN). Aptalis Pharma, Birmingham, AL.
271	Product Information. Movantik (naloxegol). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
272	Crouch MA, Limon L, Cassano AT "Clinical relevance and management of drug-related QT interval prolongation." Pharmacotherapy 23 (2003): 881-908. [PMID: 12885102]
273	Darpo B "Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes." Eur Heart J Suppl 3(Suppl K) (2001): K70-80.
274	Lopez JA, Harold JG, Rosenthal MC, Oseran DS, Schapira JN, Peter T "QT prolongation and torsades de pointes after administration of trimethoprin-sulfamethoxazole." Am J Cardiol 59 (1987): 376-7. [PMID: 3492908]
275	Wiener I, Rubin D, Martinez E, et al "QT prolongation and paroxysmal ventricular tachycardia occurring during fever following trimethoprim-sulfamethoxazole administration." Mt Sinai J Med 48 (1981): 53-5. [PMID: 6970886]

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence